Contribute Try STAT+ Today My Account

microbiome

Most Read

Probiotics illustration

Health By Meghana Keshavan

Probiotics are touted as good for the gut. They may be trouble for the immune system

ß-lactamase-producing Enterobacteriaceae

Health By Kate Sheridan

Massachusetts General Hospital oversaw trial that led to the first death from a fecal transplant, a new paper shows

purple c. difficile

Health By Kate Sheridan

CDC credits a sharp decline in C. diff infections to checklists and better antibiotic stewardship

Fusobacterium nucleatum micrograph

Biotech By Rebecca Robbins

Microbial signatures in the blood could offer new avenue for liquid biopsies to detect cancer

Fecal Transplants FDA

Health By Kate Sheridan

One dead, four hospitalized after receiving OpenBiome stool transplants

Edge of Sight

First Opinion By Scott Chimileski and Roberto Kolter

Microbes gave us life

Ubiome Kit

Biotech By Erin Brodwin

Bankrupt uBiome preliminarily sells patents for 1% of the poop-testing startup’s original valuation

Seres Therapeutics

Biotech By Kate Sheridan

Despite coronavirus disruption, major microbiome companies are cautiously optimistic about upcoming data

All Coverage

breast tumour spheroid

In the Lab By Elizabeth Cooney

Bacteria are widespread in tumors, forming distinct populations depending on the cancer type

vaginal epithelial cells

Biotech By Kate Sheridan

‘Good’ bacteria could help fight a common vaginal infection, new data show

advertisement

C. diff purple & orange

Biotech By Kate Sheridan

Rebiotix unveils positive — but preliminary — data on its microbiome drug for C. diff infections

Breastfeeding

Health By Kate Sheridan

Within months of birth, some pathogens are detectable in infants’ guts, new research shows

Biotech By Kate Sheridan

Microbiome-based drug makers are hoping new late-stage data will pull the field out of the shadows

Bacteria

Opinions Plus By Peter Bak

Microbiome drug development: a rapidly evolving field

FDA through the window

Biotech By Kate Sheridan

After an unprecedented death, FDA is offered divergent forecasts on future of fecal transplants

Fecal Transplants FDA

Biotech By Kate Sheridan

FDA to consider new evidence, risks behind fecal matter transplants for C. diff treatment

Colorful biota

Biotech By Kate Sheridan

The next frontier for the microbiome: vaginal fluid transplants that take aim at a common condition

Pharmalot By Elizabeth Cooney

Pharmalittle: Medicare will cover CAR-T; Trump health care overhaul in the wings

Biotech By Megan Thielking

Biotech, but make it beauty: Startups look to viruses and bacteria for the next generation of skin care

Wild mouse

In the Lab By Shraddha Chakradhar

Using a more diverse microbiome, scientists look to create a better lab mouse

Chickpeas

In the Lab By Shraddha Chakradhar

To tackle childhood malnutrition, researchers turn to the microbiome

microbiome runners

In the Lab By Elizabeth Cooney

Why are elite athletes different than the rest of us? Take a look at their microbes

Fecal transplant lab

Biotech By Kate Sheridan

FDA warns of one patient death from a fecal transplant

Rainbow of bacteria

Pharma By Kate Sheridan

Your gut microbiome could change the way you metabolize medicines, a new paper says

Ubiome Kit

Business By Rebecca Robbins

Troubled microbiome startup uBiome to lay off some employees, refund payments from federal insurers

Green and purple bacteria

Biotech By Kate Sheridan

A wave of NIH-backed microbiome research examines the gut’s link to diabetes, inflammatory bowel disease, and more

Fecal transplant illo

Biotech By Kate Sheridan

Microbiome therapies could be the next frontier in medicine. But how exactly do you make them?

Jessica Richman - uBiome

Business By Andrew Joseph

UBiome co-founders are placed on leave amid FBI investigation into company

Business By Rebecca Robbins

In case around microbiome startup UBiome, FBI has heard allegations involving improper billing codes and physician relationships

STAT SPOTLIGHT

Biotech By Kate Sheridan

Startup Spotlight: Flagship reveals Kintai Therapeutics — yet another microbiome company

Flora of small intestine

Biotech By Kate Sheridan

As microbiome companies develop new therapies, it’s academics who are doing the heavy lifting

Couple holding hands

Health By Kate Sheridan

Your sexual partners can change your microbiome, a new study in mice finds

Microbiome illo

Biotech By Kate Sheridan

Microbiome companies look beyond the gut for new therapies